While not a mind-blowing move, it is good to see that the Cytosorbents Corporation (NASDAQ:CTSO) share price has gained 16% in the last three months. But that doesn't change the fact that the ...

Cytosorbents Corporation (NASDAQ:CTSO) stock has reached a notable milestone, hitting a 52-week high of $1.6, signaling a period of strong performance for the medical device company. According to ...

CytoSorbents Corp (NASDAQ:CTSO) is set to release its Q4 2024 earnings on Mar 6, 2025. The consensus estimate for Q4 2024 revenue is $10.10 million, and the earnings are expected to come in at -$0 ...

CytoSorbents (CTSO) announced that it is postponing its previously announced earnings call scheduled for March 6, 2025 to allow more time to complete the annual financial audit following the ...

NASDAQ CTSO opened at $1.00 on Monday. The business has a 50 day simple moving average of $1.05 and a two-hundred day simple moving average of $1.05. Cytosorbents has a 1-year low of $0.70 and a 1 ...

Short interest in CytoSorbents Corp (NASDAQ:CTSO) increased during the last reporting period, rising from 1.93M to 1.95M. This put 3.28% of the company's publicly available shares short.

Shares of CTSO stock opened at $1.10 on Thursday. Cytosorbents has a 52 week low of $0.70 and a 52 week high of $1.61. The firm’s 50-day simple moving average is $1.03 and its two-hundred day ...